High-grade neuroendocrine neoplasms (HG-NENs) are clinically aggressive diseases, the
classification of which has recently been redefined. They now include both poorly …

High-grade (grade 3) neuroendocrine neoplasms (G3 NENs) have poor survival outcomes.
From a clinical standpoint, G3 NENs are usually grouped regardless of primary site and …

The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

Purpose: Most well-differentiated neuroendocrine tumors (WD-NET) of the enteropancreatic
system are low-intermediate grade (G1, G2). Elevated proliferation demonstrated by either a …

Neuroendocrine neoplasms are diverse in terms of sites of origin, functional status, and
degrees of aggressiveness. This review will introduce some of the common features of …

Neuroendocrine neoplasms (NENs) can develop in almost any organ and span a spectrum
from well-differentiated and indolent neuroendocrine tumours (NETs) to poorly differentiated …

Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine
organs, the nerve structures or in the so-called diffuse neuroendocrine system. The current …

Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms, arising from
neuroendocrine cells that are dispersed throughout the body. Around 20% of NETs occur in …

The bronchopulmonary (BP) and gastroenteropancreatic (GEP) organ systems harbor the
majority of the neuroendocrine neoplasms (NENs) of the body, comprising 20 and 70% of all …

Neuroendocrine tumours (NET) of the gastrointestinal tract and the lung are a rare and
heterogeneous group of tumours. The molecular characterization and the clinical …